Drug Discovery and Development | Pharmaceutical Sciences | Medicine Discovery Process | Basic Science Series
Topic of drug discovery,
How to identify therapeutic target,
Regulatory agencies,
Drug discovery,
How to do target identification,
How to identify a molecule or protein,
identification process,
progress of disease,
target has been identified,
suitable target for drug development,
Hit identification,
Potential drug candidates,
Hits,
invitro assays,
virtual screening,
Molecular dynamics simulation,
Lead optimization,
Improve its efficacy,
Pharmacokinetic properties,
clinical candidate,
efficacy and safety in preclinical studies,
Preclinical testing,
pharmacological properties,
Toxicity,
Safety.
Clinical trials,
Phase I,
safety and pharmacokinetics,
Phase II trials,
Phase III trials,
Regulatory approval,
demonstrates safety and efficacy,
Regulatory agencies,
Post-market surveillance,
any adverse effects,
during clinical trials,
drug discovery process,
Drug discovery,
WhatsApp group: chat.whatsapp.com/HTXQC1Ax2qf...
Twitter: / basic_series
Facebook Group: / 742235929758671
LinkedIn: / basic-science-series-a...
Instagram: / basic_science_series
Support my work at www.patreon.com/user?u=37177596
Disclaimer: The information provided is for educational purposes only. The content of this channel should not be considered as medical advice of any kind. Use this information at your own risk. We hold no responsibility for any issue, concerns, or damage arising from the content of the video. Under no circumstances this channel be responsible or liable in any way for any content, including but not limited to, any errors or omissions in the content, any loss, any damage of any kind incurred as a result of any content communicated in this video, whether by this channel or a third party. In no event shall this channel be liable for any special indirect or consequential damages of any damages whatsoever resulting from the content of the channel.
28 июл 2024
